• Skip to main content
  • Skip to primary sidebar
virology blog

virology blog

About viruses and viral disease

transgenic mice

A zero time point is essential

16 September 2021 by Vincent Racaniello

The recent release of grant materials from EcoHealth Alliance pertaining to their research with the Wuhan Institute of Virology has been used to demonstrate that gain of function research was funded by the NIH. This conclusion is correct, although not all the experiments done would fall into this category.

One of the figures from the released grant materials shows the results of two experiments using recombinant SARS-like coronaviruses that were constructed in the laboratory. As I described previously, after the SARS-CoV pandemic of 2003, wildlife sampling efforts in China revealed many SARS-like coronaviruses in bats. To assess the potential of these viruses for infecting humans, their spike protein encoding genes were substituted into the SARS-like CoV WIV1.

The reproduction of these recombinant viruses were assessed in two experimental systems. ACE2 transgenic mice were inoculated with the recombinant viruses to assess their pathogenic potential, by measuring weight loss. The results (figure below, left panel) show that only one recombinant virus, carrying the spike gene from SHC014, caused more rapid weight loss than did WIV-1. Hence, SCH014 has a gain of function. However the recombinant virus 4231 caused the same rate of weight loss as WIV-1 and therefore does not have a gain of function. Recombinant virus WIV-16 caused no weight loss – its curve resembles that of uninfected mice – and therefore this virus has a loss of function.

The second experiment is not, in my opinion, proof that any of these recombinant viruses have gained a new function. The experiment was to infect ACE2 transgenic mice with WIV1 and the three recombinant viruses, and then remove lung tissue at different times after infection and determine viral RNA loads. The first problem with this experiment is that RT-PCR was used to measure viral RNA loads, which does not directly measure viral infectivity. Therefore it cannot be concluded that any of the viruses reproduced to higher levels than WIV1. More problematic is that there is no time zero – the measurement of lung tissues begins at day 2. Consequently, one cannot reliably compare viral RNA loads of any of the recombinant viruses with WIV1. When doing kinetic experiments, a time zero is ALWAYS needed, so you can see how much virus was actually instilled in the mice. It gives you a baseline from which to compare subsequent time points. Even though the authors state the amount of virus added to the mice, they do not know how much was actually added. Operator error, binding to tissues, and a host of other factors can interfere early in the infection. For example, it is possible that the viral RNA loads on day 0 were the same as in subsequent time points, which showed little change over the course of the experiment. One cannot conclude from this experiment anything about the viral RNA loads without a time zero. No viruses gained any function in this experiment.

Unfortunately, many expert virologists do not have a problem with the absence of time zero. When I spoke to a reporter about these results, and told her my interpretation, she told me other ‘experts’ did not agree with me. You will find many examples of published time courses without a time zero – they are worthless.

Why the difference between virology experts? I was trained to always have a time zero; the others were not. They continue to get away with it so they believe it is correct. It is not proper research practice and no amount of arguing will make it right.

Filed Under: Basic virology, Information Tagged With: coronavirus, COVID-19, EcoHealth Alliance, gain of function, pandemic, SARS-CoV-2, transgenic mice, viral, virology, virus, viruses, Wuhan Institute of Virology

Viruses and journalism: Poliovirus, HIV, and sperm

18 December 2009 by Vincent Racaniello

polio_hivIn the summer of 1989, two papers about viruses were published in high-profile journals. One described the engineering of a recombinant poliovirus bearing on its surface an antigen from HIV-1. The second paper claimed that transgenic mice could be made by adding DNA to sperm before using them to fertilize eggs. Both reports played a role in a television interview I did with Earl Ubell of CBS News.

I was reading the Cell paper describing a new way to make transgenic mice when I received a call from CBS News. They wanted me to comment on a report that had just been released by the journal Nature, describing the production of a recombinant poliovirus bearing an antigen from HIV-1. When rabbits were inoculated with the recombinant poliovirus (the authors called it a chimeric virus), antibodies were made which could block infection with HIV-1. CBS wanted to talk because I had developed the technology to genetically engineer polioviruses.

Within an hour, science correspondent Earl Ubell arrived in my lab with a camera crew. We chatted while they set up their equipment and began to record one of my postdoctoral fellows, Gerardo Kaplan, moving about the laboratory. Ubell asked me what I thought about the polio-HIV story. I told him that it was interesting but would probably not be useful for preventing AIDS because only a small piece of HIV-1 protein could be inserted into the poliovirus capsid. Then we started talking about the sperm – transgenic mouse story, which he had heard about. I was more positive about that story; I noted that the findings could revolutionize biology.

In a few moments a microphone was clipped to my shirt and the camera began recording our conversation. Ubell began asking me questions about the polio-HIV experiment. We discussed how the virus was engineered, why it was possible to insert foreign protein into poliovirus, and the utility of this discovery. I was not positive about the future of this technology for vaccines, but I did point out its potential for research. His last question was about the sperm – transgenic mouse paper: what did I think about that? I responded, “I think that if this report is correct, then it’s going to be fabulous”. Then he packed up and left.

Several weeks later one of my students sent me a copy of the final program that had been shown on television. I was surprised to find that just one of my comments was used, and it had nothing to do with the polio-HIV story. It was the answer I had given in response to Mr. Ubell’s question about the sperm – transgenic mouse experiment, which of course was not the topic of the TV piece. I don’t know who made the juxtaposition, but I found it duplicitous. As a result of this experience, for the next 20 years I limited my contact with journalists.

Here is Mr. Ubell’s June 1989 report for CBS News. To his credit, he did get the science right, and he pronounced my name correctly. Unfortunately, while poliovirus antigen chimeras have been useful in the research lab, they have not been used as vaccines. And making transgenic mice by putting DNA into sperm turned out to be wrong.

Lavitrano, M. (1989). Sperm cells as vectors for introducing foreign DNA into eggs: Genetic transformation of mice Cell, 57 (5), 717-723 DOI: 10.1016/0092-8674(89)90787-3

Filed Under: Commentary, Information Tagged With: AIDS, HIV, journalism, poliovirus, sperm, transgenic mice, viral, virology, virus

Primary Sidebar

by Vincent Racaniello

Earth’s virology Professor
Questions? virology@virology.ws

With David Tuller and
Gertrud U. Rey

Follow

Facebook, Twitter, YouTube, Instagram
Get updates by RSS or Email

Contents

Table of Contents
ME/CFS
Inside a BSL-4
The Wall of Polio
Microbe Art
Interviews With Virologists

Earth’s Virology Course

Virology Live
Columbia U
Virologia en Español
Virology 101
Influenza 101

Podcasts

This Week in Virology
This Week in Microbiology
This Week in Parasitism
This Week in Evolution
Immune
This Week in Neuroscience
All at MicrobeTV

Useful Resources

Lecturio Online Courses
HealthMap
Polio eradication
Promed-Mail
Small Things Considered
ViralZone
Virus Particle Explorer
The Living River
Parasites Without Borders

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.